Related Experiment Video
Updated: Apr 18, 2026
09:58
A Reversible, Non-invasive Method for Airway Resistance Measurements and Bronchoalveolar Lavage Fluid Sampling in Mice
Published on: April 13, 2010
23.6K
[Bronchial hyperresponsiveness and its importance for the clinician]
1CHUV, Lausanne.
Revue Medicale Suisse
|January 22, 2015
Summary
Asthma involves airway inflammation and hyperresponsiveness. Challenge tests like methacholine and mannitol help assess asthma, but reflect different aspects of the condition.
Area of Science:
- Respiratory Medicine
- Pulmonology
- Clinical Immunology
Context:
- Asthma is a chronic airway inflammatory disease characterized by bronchial hyperresponsiveness.
- Bronchial hyperresponsiveness leads to temporary airflow limitation and symptoms like dyspnea, cough, and wheezing.
- Challenge tests are crucial for diagnosing asthma and evaluating treatment effectiveness.
Purpose:
- To explore the multifactorial origins of bronchial hyperresponsiveness.
- To differentiate the diagnostic and therapeutic implications of various challenge tests.
- To highlight the distinct mechanisms reflected by direct versus indirect challenge tests.
Summary:
- Bronchial hyperresponsiveness measurement via challenge tests aids in asthma diagnosis and management.
- Direct challenge tests (e.g., methacholine) primarily assess chronic airway remodeling.
- Indirect challenge tests (e.g., mannitol) are more indicative of current bronchial inflammation.
Impact:
- Understanding the differences between challenge tests can refine asthma diagnosis.
- Tailoring diagnostic approaches based on test type may improve treatment efficacy.
- This knowledge contributes to a more nuanced understanding of asthma pathophysiology.
Related Concept Videos
01:28Asthma I: Introduction
3
Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
3
01:13Asthma III: Clinical Manifestations
16
Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...
16
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
2
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
2
01:26Asthma-II: Pathophysiology and Classification
5.0K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
5.0K
01:20Asthma: Pathogenesis and Management
1.7K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.7K
01:25Antiasthma Drugs: β2-Adrenoceptor Agonists
2.1K
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
2.1K